Navigation Links
Bausch + Lomb Acquires Option to License New Compound to Treat Dry Eye Syndrome (DES)
Date:7/18/2013

brand, will help ensure that, if approved, this technology will reach its full potential for the millions of people suffering from DES." 

Under the terms of the agreement, Bausch + Lomb will pay Mimetogen an upfront payment as an option fee to secure the right to acquire an exclusive global license on set terms triggered by the availability of top line results from a Phase 3 study.  Should Bausch + Lomb choose to pursue development based on the Phase 3 results, the company will assume all development responsibilities and costs, and also will pay development milestones, sales milestones and royalty fees to Mimetogen.   

About Dry Eye9
Dry eye occurs when the eye does not produce enough tears, or when the tears are not of the correct consistency and evaporate too quickly.  Inflammation of the surface of the eye may also occur.  If left untreated, the condition can lead to pain, ulcers, or scars on the cornea, and some loss of vision, although permanent loss of vision from dry eye is uncommon. Dry eye can also have a significant impact on quality of life, making it more difficult to perform activities such as using a computer or reading for an extended period of time.

About Mimetogen Pharmaceuticals
Mimetogen Pharmaceuticals Inc. is a private company focused on developing the use of peptidomimetics as a novel approach to treating ophthalmic diseases with high unmet medical needs. The underlying technology was developed at McGill University and the Lady Davis Institute for Medical Research in Montreal. The company is currently developing novel therapeutic approaches for indications including dry eye disease, glaucoma and other degenerative diseases of the retina.  

About Bausch + Lomb
Bausch + Lomb is a leading global eye health company that is solely focused on protecting, enhancing, and
'/>"/>

SOURCE Bausch + Lomb
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bausch + Lomb distribuirá lentes trifocais difractivas e intraoculares tóricas da PhysIOL nos principais mercados asiáticos, europeus e do oriente médio
2. Leica Microsystems and Bausch + Lomb Sign Global Agreement for Surgical Operating Microscopes
3. Bausch + Lomb soumet une déclaration denregistrement pour un projet doffre publique initiale
4. Bausch + Lomb Files Registration Statement For Proposed Initial Public Offering
5. Bausch + Lomb ernennt Robert Bertolini zum Präsident und Chief Financial Officer
6. Bausch + Lomb designa a Robert Bertolini presidente y CFO
7. Bausch + Lomb nomme Robert Bertolini président et directeur financier
8. Bausch + Lomb Names Robert Bertolini President And Chief Financial Officer
9. Bausch + Lomb und CROMA spenden dringend benötigte Augentropfen
10. Bausch + Lomb Product, Platform and Pipeline Innovations on Display at the Annual Meeting of the American Academy of Ophthalmology
11. Bausch + Lomb Announces Final Results for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Breathe , the fastest growing online sleep apnea shopping destination ... received more than 4.5 million unique page views since the start ... many people are finding our blog and reading our articles," said ... making sleep apnea more widely known and hope that people continue ... news , troubleshooting advice , and new product launches ...
(Date:8/20/2014)... , Aug. 20, 2014  Quantum Materials ... diverse sets of patent families from Bayer Technology Services ... driver for Bayer AG of Leverkusen, ... acquired provide broad intellectual property protection for advances ... high-volume quantum dot (QD) manufacturing. In addition, the ...
(Date:8/19/2014)... BIRMINGHAM, Ala. , Aug. 19, 2014  The Alabama ... re-affirmed that patients can sue drug makers who mislead doctors ... cause harmful side‑effects.  The case is Weeks v. Wyeth, and ... drug makers in that same case last year. Heninger Garrison ... represent the patient in the case, Danny Weeks ...
Breaking Medicine Technology:Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 2Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 3Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 4Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4
... The Food and Drug Administration (FDA) has recently issued ... a "natural sexual enhancer" that contains a hidden drug ... because of a label mix-up an infusion set that ... for pregnant women (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ...
... A state-of-the-art, eFlow Technology nebulizer (PARI Pharma GmbH) has ... (Mee-us), a 27-year-old orangutan, has what veterinarians believe to ... a substantial problem in both wild and zoo orangutans. ... also have some similarities to cystic fibrosis in people. ...
Cached Medicine Technology:FDA CONSUMER HEALTH INFORMATION - FDA's MedWatch Safety Alerts: March 2011 2Denver Zoo Orangutan Breathes Easier With eFlow Technology From PARI 2Denver Zoo Orangutan Breathes Easier With eFlow Technology From PARI 3Denver Zoo Orangutan Breathes Easier With eFlow Technology From PARI 4
(Date:8/20/2014)... 2014 Transrectal ultrasound guided biopsy is the gold ... suggested that the number of risks associated with the ... Swedish researchers found that six percent of men filled ... within 30 days after having a prostate biopsy, with ... reports The Journal of Urology . , Earlier ...
(Date:8/20/2014)... Rockville Centre, NY (PRWEB) August 20, 2014 ... Martinotti and filed on August 7 in the multicounty ... New Jersey (IN RE DEPUY ASR HIP IMPLANTS LITIGATION; ... in the MCL have been dismissed without prejudice. The ... “in the process of being resolved.” The Rottenstein Law ...
(Date:8/20/2014)... IQ Formulations , a top national health and ... 500 , distinguishing it as one of the fastest growing ... made the list, but was ranked in the top 50 ... years. It also ranked ninth among all health companies, fifth ... fastest growing company in the Miami metro area. , ...
(Date:8/20/2014)... 2014 The finalists are in for ... industry trade magazine, will honor the pharmaceutical industry’s most ... given to outstanding companies, marketers and brand managers representing ... “We are proud to announce that we received our ... double the number of submissions we received last year,” ...
(Date:8/20/2014)... A Missouri federal judge has remanded a lawsuit ... with GranuFlo and NaturaLyte to the City of St. Louis ... Budd. The judge rejected an assertion by the defendants that ... (McGee, et al. v. Fresenius Medical Care North America Inc., ... is the manufacturer of the dialysis products GranuFlo and NaturaLyte. ...
Breaking Medicine News(10 mins):Health News:Severe infections with hospitalization after prostate biopsy rising in Sweden 2Health News:350 NJ DePuy ASR Lawsuits Dismissed Pending Settlement Talks, Notes Rottenstein Law Group LLP 2Health News:Leading Health Supplement Company IQ Formulations Among Inc. Magazine’s Top 50 Fastest Growing Private Companies in the United States 2Health News:PM360 Announces 2014 Trailblazer Award Finalists 2Health News:PM360 Announces 2014 Trailblazer Award Finalists 3Health News:PM360 Announces 2014 Trailblazer Award Finalists 4Health News:PM360 Announces 2014 Trailblazer Award Finalists 5Health News:PM360 Announces 2014 Trailblazer Award Finalists 6Health News:PM360 Announces 2014 Trailblazer Award Finalists 7Health News:PM360 Announces 2014 Trailblazer Award Finalists 8Health News:GranuFlo/NaturaLyte Case Remanded to State Court By Missouri Federal Judge, Baron and Budd Reports 2
... President, Congress to Include Plan in Broader Health ... now exists for the Obama Administration and Congress ... well as save approximately $35 billion over ten ... long term care reform plan, the nation,s leading ...
... Study examines why people suffer mood disorder after discharge ... that predict depression in people after they,ve been hospitalized ... Johns Hopkins researchers. , Their study involved 160 people ... distress syndrome that typically requires invasive interventions, including the ...
... Co-located Events Provide One Stop Business Forum for Beauty ... The entire product development life cycle will be on ... Global Expo and the Spa & Resort/Medical Aesthetics Expo ... opportunities. HBA Global Expo will take place September ...
... that the traditional risk factors for melanoma may not be ... thought, according to data presented at the American Association for ... clinician might look at a person with dark hair who ... for melanoma, but that may not be true for all ...
... 3000 - the latest series of wall-mounted diagnostic imaging ... Ill., April 21 MAXANT Technologies, a leader in ... the MediPort 3000, the latest innovation in its line ... of a view box, the MediPort created a new ...
... and summer weekend fun ahead in Gladstone GLADSTONE, Mich., April ... teaming up with several area groups and businesses to sponsor a ... first annual "Da, U.P. Ride for the Red" on motorcycles. ... 17, local food vendors will offer their fares. Beer and soda ...
Cached Medicine News:Health News:Avalere Health Finds New Plan to Reform Medicare Post-Acute and Long Term Care System Could Save U.S. Approximately $35 Billion Over Ten Years 2Health News:Avalere Health Finds New Plan to Reform Medicare Post-Acute and Long Term Care System Could Save U.S. Approximately $35 Billion Over Ten Years 3Health News:Avalere Health Finds New Plan to Reform Medicare Post-Acute and Long Term Care System Could Save U.S. Approximately $35 Billion Over Ten Years 4Health News:Organ Failure, Sedative Use in ICU May Lead to Depression 2Health News:HBA Global Expo and Spa & Resort/Medical Aesthetics Expo to Offer Full Spectrum of the Product Development Cycle 2Health News:HBA Global Expo and Spa & Resort/Medical Aesthetics Expo to Offer Full Spectrum of the Product Development Cycle 3Health News:Dark hair? Don't burn? Your genes may still put you at risk for melanoma 2Health News:MAXANT Launches MediPort 3000, The Next-Generation of All-In-One Workstations, on Its Newly Designed Website 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: